Trade Setup Buy Target – $39.62 Sell Target – $46.81 Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, is being developed as a rapidly acting, oral agent for the treatment of depression, neuropathic […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MorePlus, Treasury Secretary Mnuchin said the Trump administration is open to resuming talks with Democratic leaders on a new coronavirus relief bill as cases in the U.S. surpass 5 million, and Amazon is in discussions to take over old JCPenney and Sears stores to convert them into Amazon fulfillment centers.
Read MoreBuy Price: $63.00 or better Sell Price: TradersPro Sell Signal Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease […]
Read MoreOne of the biggest questions value-oriented investors have to ask themselves is the reason a stock may look like a good bargain. More often than not, one of the simplest reasons is because the stock has been beaten down by the broad market. The reasons for the decline can be multitudinous, and can imply any […]
Read More